Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
24.16
-0.01 (-0.04%)
At close: Aug 1, 2025, 4:00 PM
25.00
+0.84 (3.48%)
After-hours: Aug 1, 2025, 7:45 PM EDT
Stronghold Digital Mining Market Cap
Sanara MedTech has a market cap or net worth of $214.73 million as of August 1, 2025. Its market cap has decreased by -17.28% in one year.
Market Cap
214.73M
Enterprise Value
238.76M
1-Year Change
-17.28%
Ranking
Category
Stock Price
$24.16
Market Cap Chart
Since December 1, 1998, Sanara MedTech's market cap has increased from $5.50M to $214.73M, an increase of 3,804.19%. That is a compound annual growth rate of 14.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 214.70M | -26.02% |
Dec 31, 2024 | 290.20M | -17.30% |
Dec 29, 2023 | 350.90M | -7.12% |
Dec 30, 2022 | 377.80M | 67.54% |
Dec 31, 2021 | 225.50M | -28.21% |
Dec 31, 2020 | 314.10M | 446.26% |
Dec 31, 2019 | 57.50M | 687.67% |
Dec 31, 2018 | 7.30M | 8.96% |
Dec 29, 2017 | 6.70M | 52.27% |
Dec 30, 2016 | 4.40M | -54.64% |
Dec 31, 2015 | 9.70M | 83.02% |
Dec 31, 2014 | 5.30M | -43.62% |
Dec 31, 2013 | 9.40M | 261.54% |
Dec 31, 2012 | 2.60M | -88.79% |
Dec 30, 2011 | 23.20M | 53.64% |
Dec 31, 2010 | 15.10M | -79.17% |
Dec 31, 2009 | 72.50M | -16.38% |
Dec 31, 2008 | 86.70M | 431.90% |
Dec 31, 2007 | 16.30M | 1,937.50% |
Dec 29, 2006 | 800.00K | -66.67% |
Dec 30, 2005 | 2.40M | -86.67% |
Dec 31, 2004 | 18.00M | 8,900.00% |
Dec 31, 2003 | 200.00K | - |
Dec 31, 2002 | - | -100.00% |
Dec 31, 2001 | 3.70M | -64.42% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 682.35B |
Johnson & Johnson | 402.82B |
AbbVie | 334.40B |
UnitedHealth Group | 241.34B |
AstraZeneca | 236.88B |
Novartis AG | 227.02B |
Abbott Laboratories | 223.66B |
Novo Nordisk | 221.96B |